Member Info for Tiger16

This is a hold , some traders have jumped into AGM will get spiked they have issued a RNS once before in Dec last year in ref to the same form of deal today and then it got cancelled .. this Is the big one , i am staying put why risk when this is poised to hot 25 p this week ..

Sinnita , 100 per cent agree , no one as missed the boat here , as I thought I missed the boat here and then cam in at 7 p plus .. this will fly this afternoon .. watch .. heavy buys still coming in

The key point is that protection starts from the filing date, and that’s what matters to big pharma.

Look at past deals — Gilead with Forty Seven ($4.9B), Sanofi with Principia ($3.7B), Pfizer with Arena ($6.7B) — none of them waited for patents to be rubber-stamped. They bought in after filing + proof of concept, exactly the stage IMM is now at.

So the share price won’t sit still for years waiting on a patent office. It will be driven by RNS updates, sentiment, and especially any deal news. And remember — the RNS itself said discussions with global partners are ongoing.

On top of that, there’s a strong rumour circulating on Reddit that a deal is already in advanced stages with a major pharma. If that’s true, then the wait for a grant is irrelevant — the asset could be bought out well before then.

For me, the filing + exclusivity + huge market = the real trigger, not the admin timeline at the patent office.

MM hiding the big buys which will appear after close ..

50 p is on route here ..

One has to be crazy to sell now , it’s clear by the buying pressure here in the past week that a deal is in the making and those who know are loading up big time ..

I won’t be selling a beam as when the RNS comes this is gong to do 300 per cent in one sesssion ..

Patent grant vs. drug approval

• Patent grant:

• Yes, it can take 2–4 years for the patent office (UK/EU/US) to formally grant a patent after filing.

• But the protection starts from the filing date, so competitors are blocked from copying even while the application is pending.

• So for valuation and M&A interest, the key is that IMM filed the patent — big pharma doesn’t wait until it’s “rubber-stamped.”

• Drug approval:

• Totally separate process. This is about clinical trials + regulators (FDA/EMA/MHRA), and that’s what governs when a drug can be sold to patients.

• The new diagnostic could shorten trials, but you’re still looking at years if IMM goes it alone.

⸻

2. What drives the share price in the meantime?

• While waiting for either a patent grant or drug approval, share price (SP) moves mainly on:

• RNS updates (trial data, partnership/licensing news, financing, strategic deals).

• Market sentiment/trading flows (buys and sells, momentum, speculation).

• External catalysts (sector deals, competitor news, regulatory shifts).

The real kicker would be:

• A partnership/licensing deal with a big pharma (upfront cash + milestones).

• Or a buyout offer, which could land any time, since the IP is already filed and exclusivity claimed.

Yes, patents can take years to be granted.

• But that doesn’t delay a takeover or deal, because pharma values the patent from the moment of filing.

• The share price in the near term will be driven by RNS and investor sentiment, not by waiting years for the patent office to rubber-stamp it.

— here are some examples that show why a patent filing (not grant) is enough for a deal:

⸻

🔹 Forty Seven Inc. (Bought by Gilead, 2020)

• Stage: Mid-stage clinical trials, with IP applications still pending.

• Deal: Gilead paid $4.9 billion.

• Why: They had a unique checkpoint mechanism (CD47) with early data and filed patents. Granting wasn’t complete, but Gilead wanted exclusivity locked in.

⸻

🔹 Principia Biopharma (Bought by Sanofi, 2020)

• Stage: Early to mid-clinical, patents filed for BTK inhibitor.

• Deal: Sanofi paid $3.7 billion.

• Why: Strong IP filings + Phase II proof. Again, patents weren’t fully granted worldwide, but exclusivity was protected from the filing date.

⸻

🔹 Arena Pharmaceuticals (Bought by Pfizer, 2021)

• Stage: In trials for autoimmune drugs.

• Deal: Pfizer paid $6.7 billion.

• Why: Market demand for autoimmune pipeline. The IP position was based on filings, not all fully granted.

⸻

🔹 Why this matters for IMM

• IMM has just filed a groundbreaking patent for P140 + diagnostic test.

• Even if it takes 2–4 years to be fully “granted,” pharma already sees it as exclusive IP from the filing date.

• That means IMM could strike a licensing or buyout deal any time now — they don’t need to wait for the patent office to

Tim smith 12 , your post is absolute rubbish with no research whatsoever, probably seeking a low level entry . The aggressive buying is with smart money so forget it . Yes, patents can take years to be granted.

• But that doesn’t delay a takeover or deal, because pharma values the patent from the moment of filing.

• The share price in the near term will be driven by RNS and investor sentiment, not by waiting years for the patent office to rubber-stamp it.

here are some examples that show why a patent filing (not grant) is enough for a deal:

⸻

🔹 Forty Seven Inc. (Bought by Gilead, 2020)

• Stage: Mid-stage clinical trials, with IP applications still pending.

• Deal: Gilead paid $4.9 billion.

• Why: They had a unique checkpoint mechanism (CD47) with early data and filed patents. Granting wasn’t complete, but Gilead wanted exclusivity locked in.

⸻

🔹 Principia Biopharma (Bought by Sanofi, 2020)

• Stage: Early to mid-clinical, patents filed for BTK inhibitor.

• Deal: Sanofi paid $3.7 billion.

• Why: Strong IP filings + Phase II proof. Again, patents weren’t fully granted worldwide, but exclusivity was protected from the filing date.

⸻

🔹 Arena Pharmaceuticals (Bought by Pfizer, 2021)

• Stage: In trials for autoimmune drugs.

• Deal: Pfizer paid $6.7 billion.

• Why: Market demand for autoimmune pipeline. The IP position was based on filings, not all fully granted.

⸻

🔹 Why this matters for IMM

• IMM has just filed a groundbreaking patent for P140 + diagnostic test.

• Even if it takes 2–4 years to be fully “granted,” pharma already sees it as exclusive IP from the filing date.

• That means IMM could strike a licensing or buyout deal any time now — they don’t need to wait for the patent office to issue the certificate.

Patent grant timelines don’t block M&A.

• What matters is:

1. Patent is filed (✔️ IMM did this).

2. Proof of mechanism & early clinical data (✔️ IMM has human biology proof + Type M subgroup).

3. Market size is huge (✔️ $100B+ autoimmune market).

That’s why IMM could be bought out long before the medicine is approved or the patent is formally granted.

Hence the rush to buy here from those who have researched..

Gold girl congrats to you , as you have been a consistent holder and believed in this company .

Sincerely hope you do very well out of this and are able to support your family as you posted some time ago

Consiluim and Kev H thank you for your response . I full hearted agree with your sentiment and assessment.. of how and when to seek refuge in investing and protecting your capital, yet once in a life time we come across a stock a investment that we get emotionally attached too due to the in depth analysis we do and this is the one for me hence I will ride this one out for the end .. as I know that as the world political situation changes drastically they lean towards critical minerals that are required to survive their defence against climate catastrophe situations that are likely to occur in the future as leaders are increasingly focused on reducing their own risk against global war . Which is one of the reasons this is going to go all the way purely on expectations.. that how this market works ..

Hits 55 that was me on the WSBN group that gave all on there the heads up on this ....

Consilium and KevH I am in total agreement with your strategies and I only have 15 k in this , so I will go for the big one .. simply because I have enough evidence of research this is going to 5 p ..

However as we all know manifesting is good for the soul , lets all have this conversation when we get to 1 p .. from the rate this is moving and in 20 per cent per a day rises , we should there in a week or so .. I much prefer these 10 / 20 per cent rises then 5o per cent one day and then a re trace again the next day ..

also guys , IMM is going the same way .. DYOR .. My second largest holding ..

Out of sheer interest what other stock are you In presently ??

Kev H , you make sense , and its a good strategy , yet I have been in this for nearly a year now , and the research leads me and I say me , as this is my opinion and others I know in the game meaning Mining and Investing , as we dont see a down side here , the asset is already proven historically and some of the biggest names in geology have also confirmed the asset .. hence the only reason we are not 2 p now is the fact that investors see this as another Aim stock and are taking caution .. I am not as for me I would rather loose 15 k that I have invested here then loose 500 k if we hit 5 p which I believe is going to happen ..

Do some research on Greece and critical minerals where found many years ago , but never drilled out due to Greece not having the cash ...

ID78 , exactly .. great entry points today ..

Actually dealer all the stock I am in apart from this are seriously up and I tipped what I was in last week again before the did 50 per cent .. hello ...

Kev h if i was you , I would hold for 2 p and I believe just from the reddit group , a buy out is planed much earlier then end of year .. The big fishes will tale this out early , they will take this out after the drilling results , they wont allow this to continue proving billions under the ground in value of critical minerals , no way .. by then the price will be very high so will the competition be from the USA and China , India with buy power to buy ...

I have invested in IMM and Rock both flying and set for a serious re rate , its happening in real time , and I believe WSBN is aslo set for a re rate in two weeks time .. I have been topping up here all day .. stay strong guys and do your research ..

Rocky 123 , this prediction of a £2 buy out is actually reality , and not a pump .. as I have just researched other examples of buy outs and even £2 is very modest just to keep the asset of the market until a big Phama is ready to market it and make 100 times more .. which I know is really unfair for those who need the treatment hence I sincerely hope this is not the case and the buy out is designed to get this drug on the market asap ..

Jollifaint .. you dont understand the rise , aim sentiment .. allow me to explain , they have the biggest investment house behind them , no raises required , and the asset has been proven historically .. hence the rise , once drilling starts in 5 days ... game over it will be proven officially and then you will be lucky if you see a re entry in here under 1 p .. this is the next GGP 100 per cent ...

Guys , we just need to be patient , as I explained yesterday , those expecting a RNS on assays this week or next , its not going to happen , check my history , as I GIVEN A TIME LINE , HENCE FROM THE 23 RD SEPT ONWARDS WE WILL GET THOSE RESULTS ..

The SP will drop further , us long term holders have hedged our bets as if the assay results are what I believe they will be , this will play out as expected , and I expect serious money to be made , the flip side and this is why any new cash coming in here is limited is the fact the assay results may not be so positive , hence the traders have left and all we have now is us long term holders .. waiting for gold ..

ride the bumps , let it fall , it will rise , I HELD ROCK FOR THE PAST YEAR AND IT DROPPED ME UNDER WATER BY 50 PER CENT AND NOW I AM UP 100 PER CENT .. DYOR ...